Incidence estimation of leukemia among Koreans
- PMID: 1844638
- PMCID: PMC3049716
- DOI: 10.3346/jkms.1991.6.4.299
Incidence estimation of leukemia among Koreans
Abstract
This study was undertaken in order to estimate the incidence of leukemia among Koreans. Medical records were studied of patients with diagnoses of either ICD-9 038 (septicemia), or 204-208 (leukemias), or 284 (aplastic anemia), or 289 (other diseases of the blood and blood-forming organs) in the claims sent in by medical care institutions throughout the country to the Korea Medical Insurance Corporation (KMIC) during the period from January 1, 1986 to December 31, 1987. These records were abstracted in order to identify and confirm new cases of leukemia among the beneficiaries of KMIC, which covers about 10% of the whole Korean population. Using these data from the KMIC, the incidence rates of leukemia among Koreans were estimated as of July 1st, 1986 to June 30, 1987. The crude incidence rate of all types of leukemia among Koreans is estimated to be 3.45 (95% CI; 0.77-9.55) and 2.29 (95% CI; 0.28-7.81) per 100,000 in males and females, respectively. The cumulative rate for the age span 0-64 is 0.25% in males and 0.18% in females, and for the age span 0-74, 0.35% in males and 0.23% in females. The adjusted rates for the standard world population are 3.90 and 2.48 per 100,000 in males and females, respectively. The relative frequencies by type are 51.5% for AML, 21.6% for ALL, 20.2% for CML, and only 1.5% for CLL. The incidence patterns of various types of leukemia, of which this is the first report in Korea, are analyzed and presented.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Incidence estimation of stomach cancer among Koreans.J Korean Med Sci. 1991 Mar;6(1):7-14. doi: 10.3346/jkms.1991.6.1.7. J Korean Med Sci. 1991. PMID: 1888453 Free PMC article.
-
Incidence estimation of thyroid cancer among Koreans.J Korean Med Sci. 1991 Mar;6(1):37-44. doi: 10.3346/jkms.1991.6.1.37. J Korean Med Sci. 1991. PMID: 1888448 Free PMC article.
-
Trends in leukemia incidence and survival in the United States (1973-1998).Cancer. 2003 May 1;97(9):2229-35. doi: 10.1002/cncr.11316. Cancer. 2003. PMID: 12712476
-
The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.Expert Rev Anticancer Ther. 2003 Jun;3(3):311-29. doi: 10.1586/14737140.3.3.311. Expert Rev Anticancer Ther. 2003. PMID: 12820775 Review.
-
[Descriptive epidemiology of myeloid leukemia].Nihon Rinsho. 2009 Oct;67(10):1847-51. Nihon Rinsho. 2009. PMID: 19860178 Review. Japanese.
Cited by
-
Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.PLoS One. 2016 Dec 13;11(12):e0167641. doi: 10.1371/journal.pone.0167641. eCollection 2016. PLoS One. 2016. PMID: 27959900 Free PMC article.
-
Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):959-71. doi: 10.1098/rstb.2007.2026. Philos Trans R Soc Lond B Biol Sci. 2007. PMID: 17317642 Free PMC article. Review.
-
miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.Oncotarget. 2015 Jan 20;6(2):1276-85. doi: 10.18632/oncotarget.2626. Oncotarget. 2015. PMID: 25361012 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
